Harbor Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$224K Hold
194
– – 0.06% 79
2026
Q2
$233K Buy
+194
New +$198K 0.06% 78
2026
Q1
– Sell
-194
Closed -$208K – 81
2025
Q4
$208K Buy
+194
New +$185K 0.06% 78

Other funds holding LLY

Harbor Advisory's LLY Position: Q3 2026 in Review

Harbor Advisory held its Eli Lilly (LLY) position steady in Q3 2026 at 194 shares worth $224K. The position accounts for 0.06% of the portfolio, ranked #79.

Harbor Advisory first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $233K in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Harbor Advisory held 194 shares of Eli Lilly worth $224K as of Q3 2026.
  • Harbor Advisory left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.06% of Harbor Advisory's portfolio in Q3 2026, its #79 holding.
  • Harbor Advisory first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Harbor Advisory's Eli Lilly position peaked at $233K in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Harbor Advisory's 13F filing for Q3 2026, filed 13 Nov 2026.